Ken Griffin Phibro Animal Health Corp Call Options Transaction History

Citadel Advisors LLC

6 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	SELL	$12.44 - $18.55 $63,444 - $94,605	-5,100 Reduced 51.0%	4,900 $82,000
Q1 2024 May 15, 2024	BUY	$10.63 - $13.68 $85,040 - $109,440	8,000 Added 400.0%	10,000 $129,000
Q4 2023 Feb 14, 2024	BUY	$9.59 - $12.91 $19,180 - $25,820	2,000 New	2,000 $23,000
Q2 2023 Aug 14, 2023	SELL	$12.92 - $15.89 $31,008 - $38,136	-2,400 Reduced 28.57%	6,000 $82,000
Q1 2023 May 15, 2023	BUY	$13.67 - $16.37 $53,313 - $63,843	3,900 Added 86.67%	8,400 $128,000
Q4 2022 Feb 14, 2023	BUY	$12.05 - $15.14 $54,225 - $68,130	4,500 New	4,500 $60,000

192

20.2M

100

Ticker PAHC
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 20,337,600
Market Cap $570M
Description
Phibro Animal Health Corporation develops, manufactures, and supplies a range of animal health and mineral nutrition products for food and companion animals. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets products for poultry, swine, beef and dairy c...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.